PMID- 36555637 OWN - NLM STAT- MEDLINE DCOM- 20221226 LR - 20221227 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 23 IP - 24 DP - 2022 Dec 15 TI - Novel Small Molecule Positive Allosteric Modulator SPAM1 Triggers the Nuclear Translocation of PAC1-R to Exert Neuroprotective Effects through Neuron-Restrictive Silencer Factor. LID - 10.3390/ijms232415996 [doi] LID - 15996 AB - The neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) exerts effective neuroprotective activity through its specific receptor, PAC1-R. We accidentally discovered that as a positive allosteric modulator (PAM) of PAC1-R, the small-molecule PAM (SPAM1) has a hydrazide-like structure, but different binding characteristics, from hydrazide for the N-terminal extracellular domain of PAC1-R (PAC1-R-EC1). SPAM1 had a significant neuroprotective effect against oxidative stress, both in a cell model treated with hydrogen peroxide (H(2)O(2)) and an aging mouse model induced by D-galactose (D-gal). SPAM1 was found to block the decrease in PACAP levels in brain tissues induced by D-gal and significantly induced the nuclear translocation of PAC1-R in PAC1R-CHO cells and mouse retinal ganglion cells. Nuclear PAC1-R was subjected to fragmentation and the nuclear 35 kDa, but not the 15 kDa fragments, of PAC1-R interacted with SP1 to upregulate the expression of Huntingtin (Htt), which then exerted a neuroprotective effect by attenuating the binding availability of the neuron-restrictive silencer factor (NRSF) to the neuron-restrictive silencer element (NRSE). This resulted in an upregulation of the expression of NRSF-related neuropeptides, including PACAP, the brain-derived neurotrophic factor (BDNF), tyrosine hydroxylase (TH), and synapsin-1 (SYN1). The novel mechanism reported in this study indicates that SPAM1 has potential use as a drug, as it exerts a neuroprotective effect by regulating NRSF. FAU - Fan, Guangchun AU - Fan G AUID- ORCID: 0000-0003-2475-298X AD - Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou 510632, China. FAU - Chen, Shang AU - Chen S AD - Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou 510632, China. FAU - Liang, Lili AU - Liang L AD - Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou 510632, China. FAU - Zhang, Huahua AU - Zhang H AD - Department of Medical Genetics, Guangdong Medical University, Dongguan 523808, China. FAU - Yu, Rongjie AU - Yu R AD - Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou 510632, China. AD - Guangdong Province Key Laboratory of Bioengineering Medicine, Guangzhou 510632, China. AD - Guangdong Provincial Biotechnology Drug & Engineering Technology Research Center, Guangzhou 510632, China. AD - National Engineering Research Center of Genetic Medicine, Guangzhou 510632, China. LA - eng GR - No. 31100545, No. 31670848/National Natural Science Foundation of China/ GR - No. 2016A030313087, No. 2022A1515011158/Natural Science Foundation of Guangdong Province/ PT - Journal Article DEP - 20221215 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - 0 (Pituitary Adenylate Cyclase-Activating Polypeptide) RN - 0 (Neuroprotective Agents) RN - 0 (RE1-silencing transcription factor) RN - 0 (Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I) RN - BBX060AN9V (Hydrogen Peroxide) SB - IM MH - Cricetinae MH - Mice MH - Animals MH - *Pituitary Adenylate Cyclase-Activating Polypeptide/metabolism MH - *Neuroprotective Agents/pharmacology MH - Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I/metabolism MH - Cricetulus MH - Hydrogen Peroxide PMC - PMC9784932 OTO - NOTNLM OT - D-galactose (D-gal) OT - PAC1-R OT - SPAM1 OT - huntingtin OT - neuron-restrictive silencer factor (NRSF) OT - neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) OT - neuroprotective effect OT - positive allosteric modulator (PAM) COIS- The authors have no conflict of interest to declare. EDAT- 2022/12/24 06:00 MHDA- 2022/12/27 06:00 PMCR- 2022/12/15 CRDT- 2022/12/23 01:35 PHST- 2022/11/28 00:00 [received] PHST- 2022/12/09 00:00 [revised] PHST- 2022/12/10 00:00 [accepted] PHST- 2022/12/23 01:35 [entrez] PHST- 2022/12/24 06:00 [pubmed] PHST- 2022/12/27 06:00 [medline] PHST- 2022/12/15 00:00 [pmc-release] AID - ijms232415996 [pii] AID - ijms-23-15996 [pii] AID - 10.3390/ijms232415996 [doi] PST - epublish SO - Int J Mol Sci. 2022 Dec 15;23(24):15996. doi: 10.3390/ijms232415996.